疾病阶段是否会影响稳定性COPD的氧化应激?
Murat Yalcinsoy1, Aysegul Beykumul2, Gazi Gulbas2
1Department of Pulmonary Medicine, Inonu University Medical Faculty, Turgut Ozal Medical Center, Malatya, Turkey.
Heliyon
|June 4, 2024
概括
在稳定的慢性阻塞性肺病 (COPD) 患者中,氧化应激水平在疾病阶段之间没有显著差异. 这一发现表明,除了在恶化期间,抗炎疗法可能对稳定的COPD没有益处.
科学领域:
- 肺部医学 肺部医学
- 生物化学 生物化学
- 临床研究 临床研究
背景情况:
- 氧化应激与慢性阻塞性肺病 (COPD) 病原发生有关.
- 在稳定的COPD患者中观察到高氧化应激水平.
- 了解COPD中的氧化应激可能会揭示新的治疗点.
研究的目的:
- 调查COPD阶段是否影响炎症诱导的氧化应激的严重程度.
- 在不同GOLD阶段的稳定COPD患者中分析氧化应激参数.
主要方法:
- 连续稳定的COPD患者从门诊诊所招募 (2019年6月 - 2020年3月).
- 患者被分为GOLD阶段A,B和E.
- 氧化应激标记被评估并与患者特征和疾病阶段相关联.
主要成果:
- 总共分析了98名患者 (93.9%是男性,中位数年龄为65岁).
- 观察到FEV1,FVC和FEV1/FVC在不同组之间存在显著差异 (p < 0.001).
- 在年龄调整后,氧化应激参数在GOLD阶段是可比的,与年龄,醇和DS观察到的低水平负相关性.
结论:
- 根据GOLD分类,在稳定的COPD患者中没有发现氧化应激参数的显著差异.
- 这些发现表明,常规抗炎疗法可能不适用于稳定的COPD,并保留为急性恶化.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Pathogenesis and Clinical Features
259
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
259
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K


